GUCY1A2
Summary: Soluble guanylate cyclases are heterodimeric proteins that catalyze the conversion of GTP to 3',5'-cyclic GMP and pyrophosphate. The protein encoded by this gene is an alpha subunit of this complex and it interacts with a beta subunit to form the guanylate cyclase enzyme, which is activated by nitric oxide. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
guanylate cyclase 1 soluble subunit alpha 2 | MIM:601244 | Ensembl:ENSG00000152402 | HGNC:HGNC:4684 | PA186 | 11q22.3 |
Gene Categories:
DRUGGABLE GENOMEGO terms in GUCY1A2
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
BP | TAS | GO:0007165 | signal transduction |
BP | IEA | GO:0035556 | intracellular signal transduction |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0005525 | GTP binding |
MF | IEA | GO:0020037 | heme binding |
Gene expression in normal tissue: GUCY1A2
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in GUCY1A2
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-109582 | Hemostasis |
reactome | R-HSA-392154 | Nitric oxide stimulates guanylate cyclase |
reactome | R-HSA-418346 | Platelet homeostasis |
biocarta | no1pathway | actions of nitric oxide in the heart |
biocarta | raccpathway | ion channels and their functional role in vascular endothelium |
kegg | hsa00230 | Purine metabolism - Homo sapiens (human) |
kegg | hsa04022 | cGMP-PKG signaling pathway - Homo sapiens (human) |
kegg | hsa04270 | Vascular smooth muscle contraction - Homo sapiens (human) |
kegg | hsa04540 | Gap junction - Homo sapiens (human) |
kegg | hsa04611 | Platelet activation - Homo sapiens (human) |
kegg | hsa04713 | Circadian entrainment - Homo sapiens (human) |
kegg | hsa04730 | Long-term depression - Homo sapiens (human) |
kegg | hsa04921 | Oxytocin signaling pathway - Homo sapiens (human) |
kegg | hsa04924 | Renin secretion - Homo sapiens (human) |
kegg | hsa04970 | Salivary secretion - Homo sapiens (human) |
smpdb | SMP00050 | Purine Metabolism |
smpdb | SMP00144 | Adenosine Deaminase Deficiency |
smpdb | SMP00167 | Adenylosuccinate Lyase Deficiency |
smpdb | SMP00168 | AICA-Ribosiduria |
smpdb | SMP00203 | Molybdenum Cofactor Deficiency |
smpdb | SMP00210 | Purine Nucleoside Phosphorylase Deficiency |
smpdb | SMP00220 | Xanthine Dehydrogenase Deficiency (Xanthinuria) |
smpdb | SMP00364 | Lesch-Nyhan Syndrome (LNS) |
smpdb | SMP00365 | Gout or Kelley-Seegmiller Syndrome |
smpdb | SMP00427 | Azathioprine Action Pathway |
smpdb | SMP00428 | Mercaptopurine Action Pathway |
smpdb | SMP00430 | Thioguanine Action Pathway |
smpdb | SMP00512 | Xanthinuria type I |
smpdb | SMP00513 | Xanthinuria type II |
smpdb | SMP00535 | Adenine phosphoribosyltransferase deficiency (APRT) |
smpdb | SMP00536 | Mitochondrial DNA depletion syndrome |
smpdb | SMP00537 | Myoadenylate deaminase deficiency |
wikipathways | WP4008 | NO-cGMP-PKG mediated Neuroprotection |
wikipathways | WP4222 | Phosphodiesterases in neuronal function |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD330 | BRD4132 | 3 |
iGMDRD584 | VER 155008 | 4 |
iGMDRD512 | nutlin 3 | 4 |
iGMDRD560 | MK-2206 | 2 |
iGMDRD424 | Tamatinib | 2 |
iGMDRD85 | Ursolic acid | 1 |
iGMDRD314 | Tanespimycin | 2 |
iGMDRD219 | Bax channel blocker | 3 |
iGMDRD211 | (1S,3R)-RSL3 | 3 |
iGMDRD154 | NSC23766 | 1 |
iGMDRD251 | ML162 | 3 |
iGMDRD158 | NSC141540 | 2 |
iGMDRD271 | Brefeldin A | 3 |
iGMDRD5 | Tyrphostin AG 1478 | 3 |
iGMDRD105 | Triptolide | 5 |
iGMDRD705 | Nakiterpiosin | 2 |
iGMDRD434 | BMS-536924 | 7 |
iGMDRD871 | BRD6368 | 3 |
iGMDRD286 | Nsc 632839 | 2 |
iGMDRD872 | BRD7137 | 2 |
iGMDRD300 | Tozasertib | 3 |
iGMDRD886 | Compound 1541A | 9 |
iGMDRD246 | NPC26 | 3 |
iGMDRD126 | Tipifarnib | 7 |
iGMDRD599 | Salermide | 4 |
iGMDRD889 | Compound 7d-cis | 2 |
iGMDRD420 | Leucascandrolide A | 3 |
iGMDRD546 | BMS-754807 | 3 |
iGMDRD144 | NSC95397 | 5 |
iGMDRD670 | ML 210 | 3 |
iGMDRD494 | Neopeltolide | 1 |
iGMDRD781 | Sirolimus | 1 |
iGMDRD484 | Pluripotin | 3 |
iGMDRD316 | N9-Isopropyl-olomoucine | 1 |
iGMDRD61 | Kinetin riboside | 2 |
iGMDRD152 | 179324-69-7 | 4 |
iGMDRD679 | Bistramide A | 1 |
iGMDRD634 | SCHEMBL2608041 | 2 |
iGMDRD171 | Pemetrexed | 2 |
iGMDRD782 | DC-45-A2 | 1 |
iGMDRD187 | BRD9876 | 4 |
iGMDRD52 | Rotenone | 6 |
iGMDRD870 | BRD63610 | 7 |
iGMDRD188 | Piperlongumine | 9 |
iGMDRD100 | Zebularine | 2 |
iGMDRD399 | Selumetinib | 1 |
iGMDRD887 | Compound 23 citrate | 7 |
iGMDRD506 | Fedratinib | 4 |
iGMDRD562 | Navitoclax | 1 |
iGMDRD369 | TGX-115 | 1 |
iGMDRD60 | Quinoclamine | 6 |
iGMDRD268 | Cerulenin | 1 |
iGMDRD23 | Gossypol | 4 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in GUCY1A2